Top executives from the world’s biggest medical‑device makers say China has moved beyond being a sales outlet and a cheap‑manufacturing hub – it is now a hotbed of genuine innovation. After dozens of visits, Boston Scientific’s CEO Michael Mahoney notes that real‑world clinical needs in China are sparking rapid breakthroughs, allowing the company to test new technologies at scale and prove their effectiveness faster than anywhere else. Boston Scientific has opened a state‑of‑the‑art plant in Shanghai’s Lingang district, localising high‑end cardiovascular and urology products and even becoming one of the first markets worldwide to approve some of its latest devices. The firm is also co‑developing next‑generation coronary tools with Chinese partner Xianruida. Intuitive Surgical follows a similar path, operating its only Da Vinci robot manufacturing line outside the U.S. in Shanghai’s Zhangjiang area and running the world’s largest overseas training centre, where more than 23,000 Chinese clinicians have learned robotic surgery. Both companies stress that success in China now demands speed, agility, and deep integration with the local supply chain and research ecosystem – especially in the Yangtze River Delta and Greater Bay Area, where hospitals, universities and biotech firms cluster. In short, China is no longer just a market; it is a strategic engine driving global med‑tech innovation.
Read moreAt the recent China Medical Equipment Fair, senior leaders from multinational medical firms sounded a common warning: the Chinese market is entering an uncertain phase, and staying alive will require a shift in mindset. Wang Hao, a top executive, urged Chinese CEOs to stop seeing themselves as mere employees of foreign headquarters and start acting like entrepreneurs—taking ownership, making bold decisions, and aligning local goals with global strategy. The pressure is real. Multinationals are deepening their “localization” push, moving more production—including high‑end devices—into China, while also outsourcing logistics and upgrading factories. At the same time, the industry’s new buzzwords are digitalization, artificial intelligence and breakthrough innovation. China has become a hotbed for cutting‑edge tech, exemplified by the world’s first approved invasive brain‑computer‑interface (BCI) product and a dedicated BCI seminar hosted by Siemens Healthineers. Home‑grown champions such as United Imaging and Mindray are gaining global traction, and even appliance giant Midea has entered the medical arena. Yet experts note that medical‑device innovation still lags behind China’s fast‑moving pharmaceutical sector, and it will take more time for local manufacturers to build the deep expertise needed to compete worldwide. In short, Chinese medical executives must adopt an entrepreneurial spirit, embrace digital tools, and focus on high‑quality, innovative growth to succeed in the evolving market.
Read more